Explore

Lupus Patients Advised on Critical Sun Protection and Infection Prevention Strategies

Lupus Patients Advised on Critical Sun Protection and Infection Prevention Strategies

Individuals living with lupus are strongly advised to adopt consistent sun protection and infection prevention habits to manage their condition effectively. Ultraviolet (UV) light is a known trigger for lupus flares, affecting not only the skin but potentially causing systemic reactions days after exposure. The NHS recommends high-factor, broad-spectrum sunscreen (SPF 50 or above) and emphasizes the importance of timing outdoor activities, seeking shade, and wearing protective clothing. Studies indicate that most people apply far less sunscreen than the amount used in laboratory testing, reducing its effective SPF. Therefore, proper application technique, including generous application to all exposed areas and reapplication every two hours or after swimming/sweating, is crucial. Furthermore, lupus patients are at a higher risk of infection due to the disease itself and immunosuppressive treatments. Non-live vaccines, such as those for influenza, pneumococcal, COVID-19, and recombinant shingles, are general...

Dr. Richard Bedlack's Bold Fashion Statement Redefines ALS Patient Care

Dr. Richard Bedlack's Bold Fashion Statement Redefines ALS Patient Care

Dr. Richard Bedlack, a neurologist, is challenging traditional approaches to ALS care through his unique philosophy that integrates bold fashion and optimism. This innovative method is highlighted in the documentary film 'Stitching Strength,' which focuses on the fight against ALS, a terminal disease that progressively diminishes bodily control. Dr. Bedlack's approach emphasizes that fashion is more than just clothing; it's an expression of joy, a conversation starter, and a defense against despair, effectively becoming a form of medicine. The documentary showcases how patients, despite their diagnosis, are reclaiming their identities and expressing themselves through style. This initiative aims to transform grief into art, music, and action, demonstrating that strength and possibility can still be found even in the face of a debilitating illness. The film and Dr. Bedlack's work underscore the power of believing in what remains possible for those living with ALS.

New Research Highlights Gaps in Menopause and Multiple Sclerosis Understanding

New Research Highlights Gaps in Menopause and Multiple Sclerosis Understanding

Neuropsychologist Marit Ruitenberg has received funding from the Dutch MS Research Foundation to investigate the effects of the menopausal transition on women with Multiple Sclerosis (MS), particularly concerning cognitive symptoms. Over half of individuals living with MS are female, yet there has been limited research on how menopause impacts their cognitive abilities. The study aims to understand if cognitive issues like 'brain fog' experienced by aging women with MS are due to MS, aging, menopause, or a combination. This research was prompted by direct feedback from women with MS who reported such symptoms but found no clear answers regarding the role of menopause. Historically, women's health has been underrepresented in medical studies due to the perceived complexity of hormonal fluctuations, leading to research findings that may not fully apply to half of the population.

Rural U.S. Communities Face Significant Challenges in Early Multiple Sclerosis Diagnosis and Care

Rural U.S. Communities Face Significant Challenges in Early Multiple Sclerosis Diagnosis and Care

More than 80% of rural Americans reside in areas lacking sufficient Multiple Sclerosis (MS) specialists, leading to substantial delays and difficulties in diagnosing and treating the disease. According to research funded by the National Multiple Sclerosis Society (NMSS), patients in these 'MS specialist deserts' often face long travel times, sometimes crossing state lines, and extended wait times to see a neurologist. Early-stage MS symptoms, such as numbness, fatigue, and vision problems, are frequently overlooked or misattributed by primary care providers without specialized training, further complicating timely diagnosis. Alyssa Meller, a patient in rural Wisconsin, highlighted the unusual smoothness of her own diagnosis process, attributing her stable condition to early intervention. Organizations like the NMSS are actively working to address these gaps by enhancing resources and training for rural healthcare providers, including community health workers (CHWs), and expanding access to virtual neurolog...

High-Dose Vitamin D Linked to Improved Cognition in Older Adults with Memory Problems and Poor Sleep

High-Dose Vitamin D Linked to Improved Cognition in Older Adults with Memory Problems and Poor Sleep

A new small study conducted by Emory University scientists suggests that older adults experiencing both mild cognitive impairment and disturbed sleep may benefit from high daily doses of vitamin D. These two conditions are often considered hallmarks of early dementia. The study found that participants who took 5,000 international units (IU) or more of vitamin D daily performed better on a standard cognitive test, the Montreal Cognitive Assessment, compared to those who took no vitamin D supplements. The research involved 54 individuals with diagnosed or suspected mild cognitive impairment and sleep problems. The form of vitamin D, whether D2 (plant/fungi-derived) or D3 (sun exposure/animal-based), did not appear to affect cognitive performance. Dr. Victoria Pak, a senior author and researcher at Emory University, highlighted that this period represents a critical window for intervention, where supporting brain health may still be possible as cognitive changes emerge. The study will be published in the Octo...

Alzheimer's Disease Research Sees Major Advances as Fundraising Season Begins in Schenectady, Supported by ASAP Act

Alzheimer's Disease Research Sees Major Advances as Fundraising Season Begins in Schenectady, Supported by ASAP Act

The Alzheimer's community has witnessed significant advancements in the past year, including the approval of four new blood tests designed to detect Alzheimer's disease. These tests identify various blood biomarkers, such as fragments of the tau protein (P-tau 217), which can detect the disease up to ten years before symptoms appear. Beth Smith-Boivin, Senior Director of Coalition and Grant Initiatives for the Alzheimer's Association in New York State, highlighted the accuracy of these tests, stating they are 90% to 97% effective and can be performed on individuals as young as 40. Early detection allows for timely intervention with FDA-approved treatments, which are most effective in the disease's early stages. However, a major barrier remains: Medicare and most private insurers currently only cover these blood tests for symptomatic individuals. In response, the Alzheimer's Association is advocating for the Alzheimer’s Screening and Prevention (ASAP) Act, introduced in the House, partly by New York Congres...

Japanese Interval Walking Gains Popularity in U.S. for Health Benefits

Japanese Interval Walking Gains Popularity in U.S. for Health Benefits

Japanese Interval Walking Gains Popularity in U.S. for Health Benefits

Antibody Blocks T Cell Infiltration, Limits Neurodegeneration in Alzheimer's Mice, Offering New Therapeutic Avenue

Antibody Blocks T Cell Infiltration, Limits Neurodegeneration in Alzheimer's Mice, Offering New Therapeutic Avenue

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to reduce neurodegeneration in tauopathies, including Alzheimer’s disease. In a study using mice with Alzheimer’s-like tau protein accumulation, injecting an antibody to the CXCR3 protein blocked T cells from entering the brain, reducing their number by about half. The treated mice retained approximately 40% more tissue in memory centers and performed better on memory tests, despite no change in tau levels. This suggests that much of the damage in tauopathies may stem from the immune system's response to tau, rather than the protein itself. The antibody did not need to enter the brain tissue to be effective, only reaching its border.

National Multiple Sclerosis Society Introduces New eLearning Program for 2024 McDonald Criteria

National Multiple Sclerosis Society Introduces New eLearning Program for 2024 McDonald Criteria

The National Multiple Sclerosis Society has launched an interactive eLearning program to help clinicians implement the 2024 revisions to the McDonald Criteria for diagnosing multiple sclerosis (MS). These updated criteria represent a significant advancement, offering new pathways for earlier diagnosis while maintaining diagnostic specificity. Key changes include recognizing the optic nerve as a fifth anatomical location for dissemination in space and incorporating additional imaging and cerebrospinal fluid (CSF) biomarkers. The program aims to bridge the gap between the publication of these new diagnostic guidelines and their practical application in everyday clinical settings. It features case-based learning, interactive imaging exercises, and AI-supported patient simulations, allowing MS specialists and general neurologists to apply the revised criteria to realistic diagnostic scenarios and compare them with the 2017 criteria. The increased flexibility of the diagnostic framework necessitates appropriate...

Washington University Researchers Develop Antibody to Combat Neurodegeneration in Alzheimer's Mice

Washington University Researchers Develop Antibody to Combat Neurodegeneration in Alzheimer's Mice

Researchers at Washington University School of Medicine in St. Louis have identified a potential antibody-based treatment to reduce neurodegeneration in tauopathies, including Alzheimer's disease. In a study involving mice with Alzheimer's-like tau protein accumulation, injecting an antibody targeting the CXCR3 protein over several months successfully blocked the entry of T cells into the brain. This intervention led to a reduction of T cells in the brain by approximately half. The treated mice demonstrated preservation of about 40% more tissue in the memory centers of their brains and performed better on memory tests compared to untreated mice. Notably, these positive outcomes were achieved without altering the levels of tau protein in their brains. This research, published in Neuron, suggests that the immune system's response to tau, rather than the protein itself, is a significant contributor to the damage seen in these diseases. The study highlights the CXCR3 axis as a critical target for mitigating T ...

Greg and Ellen Jordan Donate $1 Million to Allegheny Health Network for Alzheimer's and Related Disorders Research

Greg and Ellen Jordan Donate $1 Million to Allegheny Health Network for Alzheimer's and Related Disorders Research

Greg and Ellen Jordan have committed $1 million to the Allegheny Health Network (AHN) Department of Neurology to support memory disorder research, education, and expanded care for Alzheimer's disease and related disorders (ADRD). This significant donation will establish the Greg and Ellen Jordan Endowed Professorship for Alzheimer's Disease and Related Disorders, aiming to advance innovative clinical care, neuroscience research, and support programs for patients with Alzheimer's and other forms of dementia and cognitive impairment. The investment will also enhance access to comprehensive wrap-around services designed to support patients and their families holistically, extending beyond traditional medical care. Greg Jordan, who serves as chairman of the Board of Directors of Highmark Health, stated that their support for Alzheimer's and memory care research is personal, as both he and Ellen have lost a parent to memory-related diseases. The gift will also strengthen AHN's broader investment in memory disor...

Do I have vertigo? Here's what might be causing it

Do I have vertigo? Here's what might be causing it

Experts know how to determine what is true vertigo, along with the causes and treatments.